Chris Rigg, CEO, PAM Group, joined our healthcare leaders roundtable discussion to give his viewpoint on innovation, ESG and how private equity is helping the management team at PAM to achieve their ambitions.
Backing the management team to drive organic and acquisitive growth.
PAM is one of the largest occupational health and wellbeing providers in the UK.
June 2021
Headquartered in Warrington, PAM is a leading preventative healthcare specialist. It offers a full-service of integrated occupational health and wellbeing programmes to leading blue-chip and public sector organisations, supporting more than 1.5 million employees at over 1,500 businesses.
PAM’s services include absence management, health surveillance, physiotherapy, employee assistance programmes, psychological support, corporate health assessments and neurodiversity assessments.
LDC invested in PAM in 2021 to support organic and acquisitive growth.
Doing the right thing
In 2022, the business announced its social value blueprint to help its employees, clients, stakeholders and communities to live better, healthier and happier lives. The commitment includes giving each employee 1.5 days paid leave to volunteer for a good cause, providing an
annual charity fund worth £12,000, working with job centres to provide training for the unemployed and adopting the real living wage for all employees and associates.
The team is also setting clear targets for carbon reduction – committing to keeping travel to a minimum and incorporating low carbon technology and renewable energy systems.
Acquisitive growth
In 2023 PAM completed the acquisitions of MedProtect, which provides mobile health screening to companies across the UK & Ireland, the occupational health physiotherapy business of Connect Health and provider of consultant-led occupational health services, Corporate Health Ireland (CHI).
People development
In February 2024, PAM launched a Warrington-based dedicated training academy for clinical and non-clinical staff in order to enhance routes for career development across the group.
In February 2026, LDC exchanged on the exit of PAM to Optima Health PLC, the UK’s leading provider of technology enabled corporate health and wellbeing solutions. The transaction, which values the business at £100m, has exchanged and is subject to approval from the Irish Department for Trade, Tourism and Employment’s Foreign Direct Investment regime. Further details will be announced upon completion.
Chris Rigg, CEO, PAM Group, joined our healthcare leaders roundtable discussion to give his viewpoint on innovation, ESG and how private equity is helping the management team at PAM to achieve their ambitions.